Monday, November 28, 2022
HomeNewsCOVID-19: Pfizer files for US approval for Omicron booster Vaccines for Children

COVID-19: Pfizer files for US approval for Omicron booster Vaccines for Children

Pfizer and BioNTech have requested for the United States health officials to authorize their Omicron-targeting Covid booster vaccine for children aged 5 to 11, the companies said Monday.

The companies sent a request for emergency authorization for a 10-microgram dose to the US Food and Drug Administration.

This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing more than 90% of infections in the United States.

If the FDA authorizes the vaccine, the shot will still need another green light from the Centers for Disease Control and Prevention, the country’s main federal health agency, before the first injections can be administered to children.

In the coming days, Pfizer and BioNTech will also file for authorization with the European Medicines Agency, they said.

SourceFR24

LEAVE A REPLY

Please enter your comment!
Please enter your name here